Ali Rismani
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Hematology 11
- Multiple Myeloma Research and Treatments 10
- Blood groups and transfusion 1
- Co-authors
- Shirley D’Sa (24 shared papers)Kwee Yong (13 shared papers)Neil K. Rabin (12 shared papers)Rakesh Popat (11 shared papers)Shonit Punwani (3 shared papers)Margaret Anne Hall-Craggs (3 shared papers)Magdalena Sokolska (3 shared papers)Alan P Bainbridge (3 shared papers)
- Journals
- Blood (9 papers)British Journal of Haematology (7 papers)HemaSphere (2 papers)European Radiology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomNetherlandsGermany
In The Last Decade
Ali Rismani
25 papers receiving 372 citations
Peers
Comparison fields: 5 of 24
- Hematology 158
- Genetics 36
- Rheumatology 31
- Oncology 31
- Radiology, Nuclear Medicine and Imaging 29
Countries citing papers authored by Ali Rismani
This map shows the geographic impact of Ali Rismani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rismani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rismani more than expected).
Fields of papers citing papers by Ali Rismani
This network shows the impact of papers produced by Ali Rismani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rismani. The network helps show where Ali Rismani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Rismani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 74 | |
| 2 | 2017 | 63 | |
| 3 | 2016 | 50 | |
| 4 | 2020 | 49 | |
| 5 | 2017 | 47 | |
| 6 | 2017 | 28 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 10 | |
| 9 | 2016 | 7 | |
| 10 | 2022 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2015 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2024 | 3 | |
| 15 | 2016 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2015 | 1 |
About Ali Rismani
Ali Rismani is a scholar working on Genetics, Hematology, Oncology, Rheumatology and Neurology, having authored 27 papers that have together received 377 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Cancer survivorship and care (2 papers), Atrial Fibrillation Management and Outcomes (1 paper), Peripheral Neuropathies and Disorders (1 paper), Eosinophilic Disorders and Syndromes (1 paper) and Blood groups and transfusion (1 paper). The work is most often cited by research in Hematology (158 citations), Genetics (36 citations), Rheumatology (31 citations), Oncology (31 citations) and Radiology, Nuclear Medicine and Imaging (29 citations). Ali Rismani has collaborated with scholars based in United Kingdom, Netherlands and Germany. Frequent co-authors include Shirley D’Sa, Kwee Yong, Neil K. Rabin, Rakesh Popat, Shonit Punwani, Margaret Anne Hall-Craggs, Magdalena Sokolska, Alan P Bainbridge, Arash Latifoltojar and Νικόλαος Δικαίος. Their work appears in journals such as Blood, British Journal of Haematology, HemaSphere, European Radiology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.